Cargando…

Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19

Detalles Bibliográficos
Autores principales: Diaz, Temistocles, Trachtenberg, Barry H., Abraham, Samuel J. K., KosagiSharaf, Rao, Durant-Archibold, Armando A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734129/
https://www.ncbi.nlm.nih.gov/pubmed/33330639
http://dx.doi.org/10.3389/fcvm.2020.562708
_version_ 1783622407059144704
author Diaz, Temistocles
Trachtenberg, Barry H.
Abraham, Samuel J. K.
KosagiSharaf, Rao
Durant-Archibold, Armando A.
author_facet Diaz, Temistocles
Trachtenberg, Barry H.
Abraham, Samuel J. K.
KosagiSharaf, Rao
Durant-Archibold, Armando A.
author_sort Diaz, Temistocles
collection PubMed
description
format Online
Article
Text
id pubmed-7734129
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77341292020-12-15 Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 Diaz, Temistocles Trachtenberg, Barry H. Abraham, Samuel J. K. KosagiSharaf, Rao Durant-Archibold, Armando A. Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2020-11-30 /pmc/articles/PMC7734129/ /pubmed/33330639 http://dx.doi.org/10.3389/fcvm.2020.562708 Text en Copyright © 2020 Diaz, Trachtenberg, Abraham, KosagiSharaf and Durant-Archibold. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Diaz, Temistocles
Trachtenberg, Barry H.
Abraham, Samuel J. K.
KosagiSharaf, Rao
Durant-Archibold, Armando A.
Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
title Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
title_full Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
title_fullStr Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
title_full_unstemmed Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
title_short Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
title_sort aspirin bioactivity for prevention of cardiovascular injury in covid-19
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734129/
https://www.ncbi.nlm.nih.gov/pubmed/33330639
http://dx.doi.org/10.3389/fcvm.2020.562708
work_keys_str_mv AT diaztemistocles aspirinbioactivityforpreventionofcardiovascularinjuryincovid19
AT trachtenbergbarryh aspirinbioactivityforpreventionofcardiovascularinjuryincovid19
AT abrahamsamueljk aspirinbioactivityforpreventionofcardiovascularinjuryincovid19
AT kosagisharafrao aspirinbioactivityforpreventionofcardiovascularinjuryincovid19
AT durantarchiboldarmandoa aspirinbioactivityforpreventionofcardiovascularinjuryincovid19